BIM
ADMA icon

BlackRock Investment Management’s ADMA Biologics ADMA Stock Holding History

BlackRock Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
856
– – ﹤0.01% 3788
2016
Q3 		$6K Buy
856
+148
+21% +$939 ﹤0.01% 3732
2016
Q2 		$4K Hold
708
– – ﹤0.01% 3883
2016
Q1 		$6K Hold
708
– – ﹤0.01% 3763
2015
Q4 		$6K Buy
708
+100
+16% +$900 ﹤0.01% 3814
2015
Q3 		$5K Hold
608
– – ﹤0.01% 3912
2015
Q2 		$6K Buy
+608
New +$5.26K ﹤0.01% 3892

Other funds holding ADMA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

BlackRock Investment Management's ADMA Position: Q4 2016 in Review

BlackRock Investment Management held its ADMA Biologics (ADMA) position steady in Q4 2016 at 856 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

BlackRock Investment Management first reported a position in ADMA in Q2 2015 and has held it in 7 quarters since. The position peaked at $6K in Q3 2016. 18 funds tracked by Wall St. Rank hold ADMA as of Q4 2016.

  • BlackRock Investment Management held 856 shares of ADMA Biologics worth $4K as of Q4 2016.
  • BlackRock Investment Management left its ADMA Biologics share count unchanged in Q4 2016.
  • ADMA Biologics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3788 holding.
  • BlackRock Investment Management first reported a position in ADMA Biologics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's ADMA Biologics position peaked at $6K in Q3 2016.
  • 18 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.